AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
AFTR.WS was delisted on the 3rd of August, 2023.
0 hedge funds and large institutions have $0 invested in AfterNext HealthTech Acquisition Corp Warrants in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.
100% less funds holding
Funds holding: 21 → 0 (-21)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.5M → $0 (-$1.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 21
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Segantii Capital Management
Hong Kong
|
-$1.04M |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$107K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$59.6K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$56K |
| 5 |
GAM
Gritstone Asset Management
Bethesda,
Maryland
|
-$55.1K |
AFTR.WS Hedge Fund Activity: Q3 2023 in Review
0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) for Q3 2023, worth a combined $0 — down 100% from $1.5M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of AFTR.WS and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Segantii Capital Management, exiting entirely with an estimated $1.04M sold.
- 0 institutional investors held AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) as of Q3 2023, down from 21 in Q2 2023.
- Funds reported $0 of AfterNext HealthTech Acquisition Corp Warrants stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new AfterNext HealthTech Acquisition Corp Warrants positions in Q3 2023 and 21 closed out, a net change of -21 holders.
- The largest AfterNext HealthTech Acquisition Corp Warrants seller in Q3 2023 was Segantii Capital Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q3 2023.